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• Sodium butyrate produced memory enhancement and persistence in aged rats.
• Memory formation in younger rats was not affected by sodium butyrate.
• Aged rats with normal memory might be particularly sensitive to sodium butyrate.
a r t i c l e i n f o
Article history:
Received 30 January 2015
Received in revised form 26 March 2015
Accepted 27 March 2015
Available online 30 March 2015
Keywords:
Sodium butyrate
Histone deacetylase
Inhibitory avoidance
Epigenetics
Memory consolidation
a b s t r a c t
Here we show that a systemic injection of the histone deacetylase inhibitor (HDACi) sodium butyrate
(NaB) immediately after training in a step-down inhibitory avoidance task produced an enhancement
of memory consolidation that persisted across consecutive retention tests during 14 days in aged rats,
while it did not signiﬁcantly affect memory in young adults. Control aged and young adult rats showed
comparable basal levels of memory retention. Our results suggest that HDACis can display memory-
enhancing effects speciﬁc for aged animals, even in the absence of age-related memory impairment.
© 2015 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Over the last decade, several studies have demonstrated that
transcriptional regulation involved in the formation of long-term
memories (LTM) needs the synchronized interaction of sev-
eral transcription factors and transcriptional co-activators in the
chromatin structure [1,2]. It is well established that epigenetic
mechanisms, such as histone acetylation, orchestrate molecular
events during LTM formation by relaxing or condensing the chro-
∗ Correspondingauthorat:DepartmentofPharmacology, Institute forBasicHealth
Sciences, Federal University of Rio Grande do Sul. Rua Sarmento Leite, 500 (ICBS,
Campus Centro/UFRGS), 90050-070 Porto Alegre, RS, Brazil. Tel.: +55 51 33083183;
fax: +55 51 33083121.
E-mail address: martina.blank@ufsc.br (M. Blank).
matin structure altering gene transcription [3]. Proteins named
histone acetyltransferases (HATs) add acetyl groups to lysine
residues of histones and are responsible for the modulation of
the histone-DNA interactions. The chromatin structure relaxation
leads to enhanced transcriptionwhich is a reversible process by the
action of histone deacetylases (HDACs). HDACs acts by removing
the acetyl group from lysine residues of histones and non-histone
proteins favoring the closed repressive state of chromatin [4].
Pharmacological treatment with histone deacetylase inhibitors
(HDACis), such as trichostatin A and sodium butyrate (NaB), induce
a histone hyperacetylated state regulating the accessibility of chro-
matin to the transcription machinery, affecting gene expression [5]
and the essential mechanisms acting in neurological diseases as
well as those underlying memory formation [6–8].
http://dx.doi.org/10.1016/j.neulet.2015.03.059
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HDACis were ﬁrst designed as anticancer agents [5] and the
treatment with HDACis have been shown to enhance memory and
ameliorate deﬁcits in aged rats and experimental models of mem-
ory dysfunction [8,9,10,11]. Recent evidence has demonstrated
epigenetic alterations in speciﬁc brain areas of aged animals [9,12]
that may play a crucial role in aging being correlated to diseases,
such as diabetes, cancer, neurodegenerative and psychiatric dis-
orders [13]. In the present study we sought to establish whether
HDAC inhibition by an acute systemic treatment with NaB affects
LTM formation for a one-trial inhibitory avoidance (IA) task in aged
rats.
2. Materials and methods
Young adult (3 months) or aged (20–24 months) male Wistar
rats were obtained from our institutional certiﬁed breeding colony
(CREAL-UFRGS). Animals were housed three per cage in plastic
cages with sawdust bedding and maintained on a 12h light/dark
cycle at a room temperature of 22±1 ◦C. The rats were allowed ad
libitum access food and water. Experiments using aged and young
rats were carried out separately and took place between 8 AM and
4 PM. All experimental procedures were performed in accordance
with the Brazilian Guideline for the Care and Use of Animals in
Research and Teaching (DBCA, published by CONCEA, MCTI) and
were approved by the institutional animal care committee under
protocol number 12-0424.
Animals were allowed to acclimate to the laboratory for 2h
before any experimental manipulation. One week before experi-
mentalmanipulation animalswerehandledonce aday every2days
during home-cage cleaning. We used the single-trial step-down IA
conditioning as an establishedmodel of fear-motivatedmemory. In
step-down IA training, animals learn to associate a location in the
training apparatus (a grid ﬂoor) with an aversive stimulus (foot-
shock). The general procedures for IA training and retention test
were described in previous report [14]. On training trials, rats were
gently placed on theplatform facing the left rear corner of the appa-
ratus box and their latency to step down on the grid with all four
paws was measured. Immediately after stepping down on the grid,
rats received a 0.4-mA, 3.0-s foot shock and were removed from
the apparatus. Retention test trials took place at different inter-
vals after training. No foot shock was presented during retention
test trials. No cut-off value of step-down latencies for the training
session was assigned. A ceiling of 300 s was imposed on retention
testmeasures. Step-down latencies on the retention test trialswere
used as a measure of IA memory retention. At the 21 day, rats were
given a mild reminder shock (0.3-mA, 3 s), followed by a reten-
tion test 24h later. Immediately after training rats received a single
intraperitoneal (i.p.) injection of saline (NaCl 0.9%) or NaB (1.2 g/kg;
Sigma, St. Louis, MO, USA) dissolved in saline in a 1.0ml/kg injec-
tion volume. The dose of NaB was chosen on the basis of previous
studies [10,11,15]. Rats were tested for memory retention 1 day
after training and subsequently they were submitted to test ses-
sions daily until 7 days. Animals were tested again at 14 days and
21 days after training. Additional test and reminder shock session
were performed at 23 and 24 days after training.
Western blot analysis was performed as previously described
[11,16]. Histones were extracted from hippocampal brain region of
aged rats that were systemically treated with SAL or NaB immedi-
ately after training and euthanized 1h after injections. Rats were
trained in the IA learning task (TRAINgroup), exposed to thecontext
alone (1min habituation in task chamber, HAB group) or exposed
to aversive stimulus alone (04-mA 3-s shock, SHOCK group). The
tissue was stored at −80 ◦C. The samples were homogenized (n=4
per group) in 400l of 50mM Tris, pH 7.0, 1mM EDTA, 100mM
NaF, 0.1mMPMSF, 2mMNa3VO4, 1%TritonX-100, 10%glycerol and
protease inhibitor cocktail (P2714; Sigma–Aldrich). After 20min on
ice, samples were centrifuged at 12,000 rpm for 1min. The super-
natant was collected and the same volume of 0.2-N HCl was added.
Acid extraction of histones was carried out over night at 4 ◦C then
samples were centrifuged at 6500g for 10min at 4 ◦C. The super-
natants were diluted 1/1 (v/v) in 100mM Tris, pH 6.8, 4mM EDTA,
and 8% SDS and were then boiled for 5min. The protein content
was determined by the method of Lowry modiﬁed [17]. Thereafter,
the loading buffer (40% glycerol, 100mM Tris, bromopehnol blue,
pH 6.8, 8% -mercaptoethanol) was added to the sample. Twenty-
ﬁve g total protein was separated on a 10% SDS-polyacrylamide
gel and transferred electrophoretically to a nitrocellulose mem-
brane. Membranes were blocked with 5% non-fat dry milk in TBS
containing 0.05% Tween 20 (TBS-T) and were incubated overnight
with the following antibodies: -actin at 1:3000, H3 at 1:3000,
acetyl-H3K14 at 1:1000; acetyl-H3K9 at 1:500 (ab34731, ab1791,
ab52946, ab10812; Abcam, San Francisco, CA, USA). Thereafter, the
membranes were incubated with goat anti-rabbit (ab6721, HRP)
radish-conjugated secondary antibodies and reactions were devel-
oped by chemiluminescent substrate (LumiGlo). All steps were
followed by three washes with TBS-T. The bands were quantiﬁed
using the Scion Image® software,which is a derivative ofNIH Image
(Frederick, MD, USA). Total protein levels in the blotting were nor-
malized according to each sample’s -actin protein levels and the
results were expressed as a ratio of acetylated H3 residues to total
H3.
Data are expressed as mean± SEM. Comparisons between
groups were performed using a Kruskal–Wallis analysis of vari-
ance followed by Mann–Whitney U-tests. Comparisons between
trials within the same group were performed by Wilcoxon signed-
rank test. Western blotting data were analyzed using an ANOVA
followed by a Tukey’s multiple comparison test. In all comparisons,
P<0.05 was considered to indicate statistical signiﬁcance.
3. Results
The effects of intraperitoneal administration of NaB immedi-
ately after training on the retention and persistence of IA memory
for aged rats are shown in Fig. 1. Therewas no signiﬁcant difference
between rats given SAL and NaB in training performances (P>0.05;
U 33.000). All rats were tested for retention 1 (Test 1d), 2 (Test
2d), 3 (Test 3d), 4 (Test 4d), 5 (Test 5d), 6 (Test 6d), 7 (Test 7d),
14 (Test 14d), 21 (Test 21d) and 23 (Test 23d) days after training.
Immediately after Test 23d, rats were given a reminder foot shock
and tested again 1 day later. Statistical comparison using Wilcoxon
signed-rank test showed that animals in both groups displayed
signiﬁcant memory retention on Test 1d compared to training
(P<0.001 for SAL group and P<0.01 for NaB group). Further analy-
siswithMann–Whitney U-tests showed that therewere signiﬁcant
differences between SAL-treated rats and rats given NaB in Test 1d
(P<0.01; U 103.000), Test 2d (P<0.05; U 94.000), Test 3d (P<0.01;
U 101.000), Test 4d (P<0.05; U 90.000), Test 5d (P<0.05; U 95.000),
Test 6d (P<0.05; U 92.000), Test 7d (P<0.05; U 96.000) and Test
14d (P<0.05; U 94.500), but not in the other behavioral trials. Both
groups demonstrated signiﬁcant retention levels at Reminder test
when compared to training byWilcoxon signed-rank test (P<0.001
for SAL and P<0.01 forNaB), additionally the retention level ofNaB-
treatedaged rats in theReminder testwas signiﬁcantly greater then
SAL-treated aged rats as showedbyMann–WhitneyU test (P<0.01;
U 95.000). The results indicate that NaB administration in aged rats
resulted in signiﬁcant enhancement of IA memory retention that
lasted for 14 days compared to SAL treated rats.
On the other hand, younger animals treated with NaB did not
demonstrate enhancement of IA retention (Fig. 2). Young adult rats
were treated with NaB intraperitoneally immediately after train-
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Fig. 1. Administration of NaB enhances long-term retention of IA memory in aged rats. Rats were trained and given an acute systemic intraperitoneal injection of SAL (N=12)
or NaB (1,2 g/kg, N=10) immediately after training. Data are mean+SEM retention test latencies to step-down (s); *P<0.05 and **P<0.01 compared to SAL-treated rats.
Fig. 2. Administration of NaB had no effect on long-term retention of IA memory in young rats. Rats were trained and given an acute systemic intraperitoneal injection of
SAL (N=10) or NaB (1,2 g/kg, N=10) immediately after training. Data are mean+SEM retention test latencies to step-down (s).
ing and tested for retention 1 (Test 1d), 2 (Test 2d), 3 (Test 3d),
4 (Test 4d), 5 (Test 5d), 6 (Test 6d), 7 (Test 7d), 14 (Test 14d), 21
(Test 21d) and 23 (Test 23d) days after training. Immediately after
Test 23d, rats were given a reminder footshock and tested again
1 day later. Although both groups demonstrated memory reten-
tion on Test 1d compared to training by Wilcoxon signed-rank test
(P<0.01 for both groups), no memory enhancement was observed
in the group treated with NaB in comparison to SAL-treated group
by furtherMann–WhitneyU-tests. In addition, no signiﬁcant differ-
ences between SAL-treated rats and rats given NaB were observed
in any other trial. There was a decline in retention levels across
test trials, and both groups displayed a high retention level when
testedafter a reminder shock (P<0.01compared to training forboth
groups). The results indicate that NaB had no effect on learning in
young adult rats.
In order to investigate if the pharmacological effects of NaB
observed in aged rats during learning reﬂected biochemical
alterations in speciﬁc histones modiﬁcations, we examined the
acetylation level of histone H3 in both residues of lysine 9 and 14
in the hippocampus of aged rats. We chose those residues because
histone acetylation of H3 lysine residues has been linked to mem-
ory formation and consolidation [15,32]. In addition, Peleg et al.
[9] had found a transient increase of H3K9 and H3K14 acetylation
60min in the hippocampus after fear conditioning in 3 and 16-
month-old mice and Silva et al. [11] demonstrated that memory
impairment induced by brain iron overload is accompanied by a
reduction in H3K9 acetylation in the hippocampus that is rescued
after treatment with NaB. Fig. 3A and B shows Histone H3 acetyla-
tion at lysine 9 and 14 in the hippocampus of aged rats treatedwith
SAL or NaB. Systemic NaB treatment immediately after training did
not affect H3K9 and H3K14 acetylation in aged rats measured 1
hour post-training. Although there was an apparent NaB-induced
increase inH3K9 acetylation in trained rats compared to SAL group,
this comparison did not reach statistical signiﬁcance (P>0.05).
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Fig. 3. Histone H3 acetylation in the hippocampus of aged rats treated with SAL or NaB. Rats were either trained in the IA learning task (TRAIN), exposed to the context
alone (HAB) or exposed to aversive stimulus alone (SHOCK). Data are shown as means± SEM ratio of acetylated H3K9 (A) or H3K14 (B) to total histone H3. (C) Representative
Western blots for acetylated histones, total H3, and -actin in the hippocampus; N=4 animals per group.
4. Discussion
Recent evidence indicates that epigenetic mechanisms can
orchestrate molecular events during long-term memory formation
and affect learning in aged rats [2,6,7,8,9,10,12,15,18]. Our data
indicate that treatment with NaB can enhance memory consolida-
tion for aged rats but not young adult rats. In addition, it supports
the view of learning being critically modulated by the activity of
HDACs [3,19]. Since NaB injections were given after training, the
NaB-induced improvement of memory observed in aged rats can-
not be explained by drug-induced alterations in sensorial or motor
parameters.
Kilgore et al. [8] showed that beyond rescuing memory deﬁcits
in a mouse model of Alzheimer’s disease, treatment with HDACis
resulted in a type of memory resistant to weakening in response
to time or reactivation. Consistently, we found that the enhanced
memory was more persistent lasting longer even with daily re-
exposure to the IA apparatus when compared to control aged
animals. Therefore, HDACis might be regulating mechanisms of
plasticity generating stability and improving the efﬁciency of orig-
inal memory consolidation when administered at speciﬁc time
points after learning. This is in accordance with our previous
results [14] and with evidence indicating that increased acetyla-
tion induced byHDACis is amolecular feature of stronger andmore
persistent memories [20]. Further studies are necessary to under-
stand which mechanisms are being modulated by NaB in aged rats
and additional tests evaluating memory in different time points
after training and NaB administration are important to clarify this
memory-enhancing effect.
Previously, our group has demonstrated that a posttraining
injection of NaB did not affect memory in younger rats showing
normal memory retention, but ameliorated aging-related mem-
ory deﬁcits in an object recognition task [10,11]. Our ﬁndings
extend that previous evidence by indicating that NaB can display
a memory-enhancing effect that is speciﬁc for aged animals, even
when they do not show age-related memory impairment. Many
studies showed memory-enhancing effects of HDAC inhibitors in
young rodents [7,8,15,18,21] but, in our study no effect of NaB was
observed in young rats. Perhaps the null effect of NaB observed
in young rats could be explained by differences in behavioral
protocols and route of administration used that may reﬂect a com-
plex action of NaB since there are variations of NaB effects across
research laboratories. The hypothesis that animals with different
genetic backgrounds can present different behavioral responses as
well as diverse patterns of epigenetic modiﬁcations should also be
taken into account when comparing different studies [8].
In our study, aged animals with no learning deﬁcits were selec-
tively affected by NaB administration. This result is in accordance
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with studies demonstrating that aging is not always accompanied
by memory impairment as nearly half of aged rats demonstrate
normal learning scores [23,24,25,26,27]. Furthermore, different
patterns of chromatin modiﬁcations occur in the hippocampus
of young and aged rats after training and the use of HDACis
might alter chromatin resulting in divergent gene transcription and
behavioral responses [23,26]. Haberman and co-workers [26,27]
demonstrated that although some gene proﬁles are the same
between young and aged rats with no impaired memory, many
other genes are differentially expressed. Thus, perhaps treatment
with NaB could be altering gene expression by acting on those
genes promoters. Our ﬁnding of speciﬁcmemory-enhancing effects
of NaB in aged rats could also be partly explained by the fact that
epigeneticmarkers at histonesmaynot bederegulated in these ani-
mals and possiblyHDACs inhibition byNaB is affecting non-histone
substrates [31].
The lack of alterations in H3 acetylation for aged rats in our
work might be explained by transient variations in acetylation on
numerous histones, not only in histone H3, triggered by memory
formation [9,28]. Studies with altered H3 acetylation used object
recognition training, contextual fear conditioning, spatial memory,
food aversion training among others that differ from our IA train-
ing which could result in a different pattern of histone acetylation
[29]. Peleg et al. [9] showed that age-related memory impairment
was associated with a reduction in acetylation of H4K12, but not
H3K9. In addition, Castellanoet al. [22]demonstrated that increases
in H3 acetylation after systemic administration of NaB occurred
30min after injection but not at 60min. NaB also act on HDACs
with ubiquitous expression probably inducing acetylation in other
substrates aside from nuclear histones [30]. Recently, enzymatic
cleavage of histone H3 tail was reported in vivo [33] and it could
interferewithhistoneacetylationbiochemicalmeasures sincemost
studied modiﬁcations in histone H3 are located downstream of
known H3 cleavage sites. Future experiments investigating acety-
lation in other lysine residues, comparing histone acetylation in
aged and young rats as well as in habituated rats with naïve and
non-habituated control rats might shed light on this issue.
5. Conclusion
In summary, our results indicate that aged animals, even with
the absence of alterations in normal memory formation, might be
particularly sensitive to the enhancing effects of a single systemic
administration of an HDACi on the consolidation of aversively-
motivated memory.
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